Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Precision Biosciences Inc shares valued at $63,163 were sold by Kelly John Alexander on Jul 03 ’25. At $4.26 per share, Kelly John Alexander sold 14,827 shares. The insider’s holdings dropped to 73,485 shares worth approximately $0.34 million following the completion of this transaction.
Also, Kelly John Alexander purchased 14,827 shares, netting a total of over 63,208 in proceeds.
Before that, Brown Melinda had added 1,682 shares to its account. In a trade valued at $6,963, the Director bought Precision Biosciences Inc shares for $4.14 each. Upon closing the transaction, the insider’s holdings increased to 1,682 shares, worth approximately $95421.59999999999.
As published in a research note from BMO Capital Markets on January 10, 2025, Precision Biosciences Inc [DTIL] has been rated up from a Market perform to an Outperform and the price target has been revised to $34. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in late April. As of June 17, 2022, BMO Capital Markets has initiated its “an Outperform” rating for DTIL. Earlier on June 09, 2022, William Blair downgraded its rating. Their new recommendation was “a Mkt perform” for DTIL stock which previously was a “an Outperform”.
Analyzing DTIL Stock Performance
On last trading session,, Precision Biosciences Inc [NASDAQ: DTIL] rose 2.65% to $4.64. The stock’s lowest price that day was $4.4, but it reached a high of $4.87 in the same session. During the last five days, there has been a drop of approximately -3.93%. Over the course of the year, Precision Biosciences Inc shares have dropped approximately -54.69%.
Support And Resistance Levels for Precision Biosciences Inc (DTIL)
RSI (Relative Strength Index) is 50.66 on the 14-day chart, showing neutral technical sentiment.
Is Precision Biosciences Inc subject to short interest?
Stocks of Precision Biosciences Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.1 million shares to 0.55 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 0.65 million shares. A decline of -18.45% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.13 of the overall float, the days-to-cover ratio (short ratio) decline to 7.13.
Which companies own the most shares of Precision Biosciences Inc (DTIL)?
In terms of Precision Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 15.5 in the next 12 months, up nearly 242.92% from the previous closing price of $4.52. Analysts anticipate Precision Biosciences Inc stock to reach 30 by 2025, with the lowest price target being 1. In spite of this, 3 analysts ranked Precision Biosciences Inc stock as Buy at the end of 2025. On July 27, 2020, BTIG Research assigned a price target of “a Buy” to the stock and resumed coverage with a $16.
